VJOncology is committed to improving our service to you

VJVirtual | LADIE study: NSCLC in women

VJOncology is committed to improving our service to you

Benjamin Besse

Benjamin Besse, MD, PhD, of Institut Gustave Roussy, Villejuif, France, highlights data published on the IFCT-1003 LADIE study. This phase II randomized study evaluated the treatment of patients with EGFR-TKI alongside fulvestrant, an anti-estrogen therapy, in women with non-squamous advanced stage non-small cell lung cancer. The study concluded that adding fulvestrant to EGFR-TKI is feasible, but not associated with prolonged PFS regardless EGFR status. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter